CNTO 1275 : Moving into Phase Three of FDA TrailsPsoriasis Cure Now is a non-profit patient advocacy group documenting the results of clinical trials testing CNTO 1275 as a cure for psoriasis.  The results have been favorable.  Psoriasis is a chronic skin condition resulting in red inflamed skin which can also be extremely dry with flaky patches.  Many who suffer from sever cases may have given up hope but CNTO 1275 has shown remarkable results.  During the clinical trials, 81 percent of patients receiving four weekly doses resulted in a 75 percent improvement to their skin’s condition also 20 percent of the patients actually resulted in a 100 percent success rate.  The results of one simple injection  (verses continuous treatment) were just as well, 59 percent achieved 75 percent improvement and 16 percent of patients again  were completely cured.  If the treatment is deemed safe and approved by the FDA it will be a powerful treatment to finally clear the skin of those who suffer from sever psoriasis.

For more info visit Psoriasis Cure Now    [ Via MedicalNewsToday.com ]

FDA Trials, Psoriasis, Dermatology, Treatment
Email This Post Email This Post